Skip to main content

Table 1 Characteristics of the cohort

From: Skeletal muscle wasting and long-term prognosis in patients undergoing rectal cancer surgery without neoadjuvant therapy

Variables

 

Included patients N = 129

Median (IQR)/N (%)

Age

Years

72 (62–78)

Sex

Females

48 (37.2)

BMI

 

25.3 (23.4–27.8)

CCI

5 (4–7)

ASA score

1

4 (3.1)

2

66 (51.2)

3

59 (45.7)

Type of surgery

Anterior resection

94 (72.9)

Miles procedure

21 (16.3)

Hartmann procedure

14 (10.8)

Laparoscopy

 

63 (48.8)

Overall morbidity

 

43 (33.3)

Clavien-Dindo classification

< 3

27 (20.9)

≥ 3

15 (11.6)

Redo surgery

 

8 (6.2)

Anastomotic leakagea

 

8/94 (8.5)

Tumor location

High

64 (49.6)

Middle

41 (31.8)

Low

24 (18.6)

TNM stage

I

30 (23.3)

II

33 (25.6)

III

41 (31.8)

IV

13 (10.1)

Positive resection margin

 

11 (8.5)

Adjuvant chemotherapy

 

61 (47.3)

  1. BMI body mass index, CCI Charlson comorbidity index, ASA American Society of Anesthesiologists
  2. aCalculated on the number of patients who underwent restorative surgery